Sanofi Genzyme always endeavours to provide a high standard of service to both treating doctors and their patients. Our dedication to patients extends beyond the development of products. We've initiated numerous free drug and humanitarian programs to ensure that vital treatment reaches all those who need it.
At Sanofi Genzyme we recognise the need for patients to have access to ongoing support. We have therefore worked with the South African patient organisation to ensure that patients have people to turn to for help and emotional support. The patient organisation can put them into contact with one another so that they can share their experiences and support each other.
We strive to deliver optimal treatment and reimbursement assistance for the following Lysosomal Storage Disorders: Gaucher, Pompe, MPS 1, & Fabry disease as well a drug that is used to monitor patients with thyroid cancer.